Chronic pain can feel overwhelming and unmanageable for many patients, but with the right tools, we can empower them to take back control. The "Painless" series is a comprehensive, step-by-step resource designed to guide patients through understanding and managing their pain effectively.

WEST PALM BEACH, FL, Dec. 13, 2024 (GLOBE NEWSWIRE) -- QHSLab Inc. ("the Company") (OTCQB: USAQ), a leading provider of digital healthcare solutions and diagnostic technologies, is thrilled to announce that it has been invited by the prestigious National Science Foundation (NSF) to submit a full Phase I application for the development of the Airway Instantaneous Regional Guided Interface for Drug Delivery Efficiency (AIR-GUIDDE). This exclusive invitation, under the NSF Small Business Technology Transfer (STTR) program, underscores the transformative potential of AIR-GUIDDE and highlights the significant merits of the project, even at this early stage.

In our practice, we sometimes meet patients facing significant health risks who aren't ready to seek help. This reluctance might stem from stigma, cost concerns, mistrust, or simply not feeling prepared to make changes. These moments, while challenging, offer a chance to connect with our patients thoughtfully.

“The bottom line of the study is that yes, this association exists,” Sanchez-Gonzalez told Healio. “Many of these patients use over-the-counter medications. They don’t necessarily have their allergy symptoms under control and these allergy symptoms might feed into that anxiety and depression.”

As healthcare providers, we often manage multiple tasks simultaneously—searching for patient information, writing reports, billing, and coding—all while trying to provide the best care possible. This can be overwhelming and take valuable time away from our patients. QHSLab offers a solution to these common frustrations through our Integrated Service Program (ISP), designed to simplify and streamline patient care.

QHSLab is pleased to announce the addition of Dr. Juan D. Oms, a board-certified psychiatrist with extensive expertise in behavioral health and substance use disorders, as a medical advisor. Dr. Oms will provide strategic guidance in integrating advanced digital healthcare solutions to support the mental health and substance misuse and/or abuse needs of patients in primary care settings.